Interstitial lung disease and Pericarditis

Summary:

Pericarditis is found among people with Interstitial lung disease, especially for people who are female, 40-49 old.

The study analyzes which people have Pericarditis with Interstitial lung disease. It is created by eHealthMe based on reports of 13 people who have Interstitial lung disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,500 drugs and 1,841 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

What is Pericarditis?

Pericarditis (inflammation of the pericardium) is found to be associated with 860 drugs and 941 conditions by eHealthMe. Check the latest studies of Pericarditis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

13 people who have Interstitial Lung Disease and Pericarditis are studied.

Would you have Pericarditis when you have Interstitial lung disease?

Gender of people who have Interstitial Lung Disease and experienced Pericarditis *:

  • female: 83.33 %
  • male: 16.67 %

Age of people who have Interstitial Lung Disease and experienced Pericarditis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50.0 %
  • 50-59: 16.67 %
  • 60+: 33.33 %

Common co-existing conditions for these people *:

  1. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 6 people, 46.15%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 38.46%
  3. Myopathy (a muscular disease in which the muscle fibres do not function): 1 person, 7.69%
  4. Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 7.69%
  5. Dyslipidaemia (abnormal amount of lipids): 1 person, 7.69%
  6. Cardiac Failure: 1 person, 7.69%

Common drugs taken by these people *:

  1. Methylprednisolone: 12 people, 92.31%
  2. Acetaminophen: 11 people, 84.62%
  3. Prednisone: 6 people, 46.15%
  4. Diphenhydramine Hydrochloride: 6 people, 46.15%
  5. Dimenhydrinate: 6 people, 46.15%
  6. Tacrolimus: 1 person, 7.69%
  7. Prednisolone: 1 person, 7.69%
  8. Furosemide: 1 person, 7.69%
  9. Esbriet: 1 person, 7.69%

Common symptoms for these people *:

  1. Nasopharyngitis (inflammation of the nasopharynx): 6 people, 46.15%
  2. Oropharyngeal Pain: 6 people, 46.15%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 6 people, 46.15%
  4. Chest Pain: 6 people, 46.15%
  5. Cough: 6 people, 46.15%
  6. Headache (pain in head): 6 people, 46.15%
  7. Throat Irritation: 5 people, 38.46%
  8. Night Sweats (sweating in night): 1 person, 7.69%
  9. Neck Pain: 1 person, 7.69%
  10. Nausea (feeling of having an urge to vomit): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Pericarditis?

- Check whether Pericarditis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Pericarditis:

All the conditions that are associated with Pericarditis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Pericarditis and Interstitial lung disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: